Drug intelligence / Profile preview

cholecystokinin

Development stage
Approved
Lead developer
Boehringer Ingelheim
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Cholecystokinin is a peptide hormone and neuropeptide primarily produced by enteroendocrine cells in the duodenum and also found in neurons of the central and enteric nervous systems. It plays a key role in digestion by stimulating gallbladder contraction to release bile and promoting pancreatic enzyme secretion. Cholecystokinin acts as an agonist at cholecystokinin receptors (mainly type A/CCK1) to mediate these effects. It also delays gastric emptying, relaxes the sphincter of Oddi, inhibits gastric acid secretion, increases intestinal motility, and induces satiety via actions on both peripheral tissues and the brain. Clinically, exogenous cholecystokinin or its synthetic analogs are used as diagnostic aids for evaluating gallbladder function (e.g., during HIDA scans) or pancreatic insufficiency[1][5][6]. In research settings, fragments like CCK-4 are used to study anxiety mechanisms due to their ability to induce panic symptoms[2]. The only FDA-approved pharmaceutical form is sincalide.

Brand names
sincalide
Other names
cholecystokininpancreozyminCCK-8CCK8CCK 8CCK-4CCK4CCK 4
02

Targets

CCKAR (Cholecystokinin A receptor)

Beyond the preview

Go deeper on cholecystokinin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cholecystokinin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call